Y-Intercept (HK)’s Dyne Therapeutics DYN Stock Holding History

Y-Intercept (HK)’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.47M	Buy	156,203 +91,045	+140%	+$1.69M	0.07%	420
2026 Q1	$1.18M	Sell	65,158 -278,568	-81%	-$4.8M	0.02%	954
2025 Q4	$6.72M	Buy	+343,726	New	+$6.51M	0.15%	139
2025 Q3	–	Sell	-124,628	Closed	-$1.19M	–	1679
2025 Q2	$1.19M	Buy	124,628 +43,963	+55%	+$484K	0.03%	857
2025 Q1	$844K	Buy	80,665 +70,897	+726%	+$1.01M	0.06%	477
2024 Q4	$230K	Sell	9,768 -19,926	-67%	-$589K	0.02%	1013
2024 Q3	$1.07M	Buy	+29,694	New	+$1.18M	0.07%	425

Other funds holding DYN

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

DWM

Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Y-Intercept (HK)'s DYN Position: Q2 2026 in Review

Y-Intercept (HK) increased its Dyne Therapeutics (DYN) stake by 140% in Q2 2026, buying an estimated $1.69M and bringing the position to 156,203 shares worth $3.47M. The position accounts for 0.07% of the portfolio, ranked #420.

Y-Intercept (HK) first reported a position in DYN in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.72M in Q4 2025. 27 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

Y-Intercept (HK) held 156,203 shares of Dyne Therapeutics worth $3.47M as of Q2 2026.
Y-Intercept (HK) bought 91,045 Dyne Therapeutics shares in Q2 2026, an estimated $1.69M.
Dyne Therapeutics made up 0.07% of Y-Intercept (HK)'s portfolio in Q2 2026, its #420 holding.
Y-Intercept (HK) first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 7 quarters since.
Y-Intercept (HK)'s Dyne Therapeutics position peaked at $6.72M in Q4 2025.
27 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.